HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Experimental infection of immunomodulated NOD/LtSz-SCID mice as a new model for Plasmodium falciparum erythrocytic stages.

Abstract
The main objective of this study was to determine whether a chemical immunomodulation protocol could reduce the resistance of NOD/LtSz-SCID mice to Plasmodium falciparum infection and provide an improved mouse model for screening the antimalarial activity of new compounds. This model was compared with the presently used immunodeficient Beige/Nude/Xid (BNX) mouse model, using the same protocol, in terms of percentage of infected mice, parasite development, leukocyte response and phagocytosis of P. falciparum infected cells in various organs. Our results show that the combination of the chemical immune modulation protocol with the genetic background of NOD/LtSz-SCID mice results in the development of long-lasting P. falciparum infection in a high percentage of mice. A comparison of the results obtained in the histological study for both mouse models suggests that the higher rate of success in NOD/LtSz-SCID mice could be related to the reduced macrophage recruitment developed in different tissues to remove the parasite from blood.
AuthorsAlicia Moreno Sabater, Marta Moreno, Francisco Javier Moreno, Cesar Eguiluz, Nico van Rooijen, Agustin Benito
JournalParasitology research (Parasitol Res) Vol. 95 Issue 2 Pg. 97-105 (Jan 2005) ISSN: 0932-0113 [Print] Germany
PMID15592938 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antimalarials
Topics
  • Animals
  • Antimalarials (pharmacology)
  • Disease Models, Animal
  • Drug Evaluation, Preclinical
  • Erythrocytes (parasitology)
  • Humans
  • Immune Tolerance
  • Macrophages (immunology, parasitology)
  • Malaria, Falciparum (drug therapy, etiology, immunology)
  • Mice
  • Mice, Inbred NOD
  • Mice, Nude
  • Mice, SCID
  • Phagocytosis
  • Species Specificity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: